Home » Stocks » BNGO

BioNano Genomics, Inc. (BNGO)

Stock Price: $0.497 USD 0.007 (1.37%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $0.500 +0.003 (0.60%) Dec 3, 7:59 PM

Stock Price Chart

Key Info

Market Cap 76.13M
Revenue (ttm) 7.30M
Net Income (ttm) -37.28M
Shares Out 132.94M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $0.497
Previous Close $0.490
Change ($) 0.007
Change (%) 1.37%
Day's Open 0.500
Day's Range 0.490 - 0.505
Day's Volume 4,796,068
52-Week Range 0.260 - 1.270

More Stats

Market Cap 76.13M
Enterprise Value 73.28M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 132.94M
Float n/a
EPS (basic) -0.40
EPS (diluted) -0.52
FCF / Share -0.27
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 7.34M
Short Ratio 2.01
Short % of Float n/a
Beta 1.50
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 10.42
PB Ratio 5.10
Revenue 7.30M
Operating Income -34.60M
Net Income -37.28M
Free Cash Flow -35.72M
Net Cash 2.85M
Net Cash / Share 0.02
Gross Margin 46.03%
Operating Margin -473.82%
Profit Margin -510.40%
FCF Margin -489.07%
ROA -68.24%
ROE -1,021.64%
ROIC -604.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$1.48*
(197.79% upside)
Low
1.15
Current: $0.497
High
2.00
Target: 1.48
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue10.1312.009.516.79
Revenue Growth-15.59%26.26%39.93%-
Gross Profit3.363.293.473.21
Operating Income-25.87-20.42-23.22-21.17
Net Income-29.82-18.50-23.37-18.85
Shares Outstanding14.987.082.7060.32
Earnings Per Share-1.99-2.61-8.65-312.46
Operating Cash Flow-29.53-19.94-20.82-23.50
Capital Expenditures-0.06-0.33-1.02-1.35
Free Cash Flow-29.59-20.28-21.84-24.85
Cash & Equivalents17.3116.521.025.25
Total Debt20.099.036.736.63
Net Cash / Debt-2.777.49-5.71-1.38
Assets30.2124.8010.1514.79
Liabilities26.5914.6717.3616.63
Book Value3.6110.14-50.23-27.26
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioNano Genomics, Inc.
Country United States
Employees 97
CEO R. Erik Holmlin

Stock Information

Ticker Symbol BNGO
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BNGO
IPO Date August 21, 2018

Description

Bionano Genomics operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.